Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
US Department of Justice
Argus Health
McKinsey
Harvard Business School
Boehringer Ingelheim
Daiichi Sankyo
Johnson and Johnson

Generated: December 12, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076793

« Back to Dashboard

NDA 076793 describes FLUTICASONE PROPIONATE, which is a drug marketed by Anda Repository, Fougera Pharms, G And W Labs, Nesher Pharms, Perrigo New York, Glenmark Generics, Perrigo Israel, Taro Pharm Inds, Apotex Inc, Hi Tech Pharma, West-ward Pharms Int, and Wockhardt Bio Ag, and is included in seventeen NDAs. It is available from seventy-six suppliers. Additional details are available on the FLUTICASONE PROPIONATE profile page.

The generic ingredient in FLUTICASONE PROPIONATE is fluticasone propionate. There are twenty-eight drug master file entries for this compound. Eighty-four suppliers are listed for this compound. Additional details are available on the fluticasone propionate profile page.
Summary for 076793
Tradename:FLUTICASONE PROPIONATE
Applicant:Perrigo New York
Ingredient:fluticasone propionate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 076793
Suppliers and Packaging for NDA: 076793
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FLUTICASONE PROPIONATE fluticasone propionate CREAM;TOPICAL 076793 ANDA Perrigo New York Inc 45802-222 45802-222-11 1 TUBE in 1 CARTON (45802-222-11) > 30 g in 1 TUBE
FLUTICASONE PROPIONATE fluticasone propionate CREAM;TOPICAL 076793 ANDA Perrigo New York Inc 45802-222 45802-222-35 1 TUBE in 1 CARTON (45802-222-35) > 15 g in 1 TUBE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.05%
Approval Date:May 14, 2004TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Queensland Health
Healthtrust
Boehringer Ingelheim
Argus Health
US Army
Express Scripts
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.